Fractional leadership

Fractional Chief AI Officer

A fractional Chief AI Officer is an experienced executive who holds accountability for an organization’s AI portfolio part-time — what gets deployed, what gets stopped, and who answers when a model fails in production.

What is a fractional Chief AI Officer?

A fractional Chief AI Officer is a senior executive who holds accountability for an organization’s AI portfolio on a part-time, defined engagement rather than as a permanent hire. In a health system that means four things concretely: the model inventory, the deploy / don’t-deploy decision, clinical escalation when a model is wrong, and regulatory posture. The test of the role is whether the person can stop a deployment — not just comment on one.

A Chief AI Officer — fractional or permanent — is the executive accountable for how an organization adopts and governs artificial intelligence: which systems are approved, who owns them once they are in production, and how failures are caught and escalated. The fractional version is that same accountability, held part-time under a defined engagement instead of as a full-time hire.

It is distinct from a Chief Data Officer, and the distinction is the thing most organizations get wrong when they scope the role. A CDAO answers “can we trust our numbers.” A CAIO answers “should we deploy this, who owns it once it’s live, and what happens the night it gets something wrong.”

What the Role Actually Owns

Most health systems have AI tools in production and nobody whose job it is to own them.

The model inventory

Knowing what is actually running — including the ambient documentation tool a service line bought directly and the vendor feature that turned on in an upgrade. Most systems cannot produce this list, which is the first finding of every AI audit.

Deploy / don’t deploy

A real gate with a named owner and the authority to say no. Committees that can only advise produce approvals by exhaustion, and the exception that gets waved through is the one in the postmortem.

Clinical accountability

Who is called when the model is wrong, what the escalation path is at 3 a.m., and whether the clinician overriding it is supported or second-guessed. This is where accuracy stops being the question.

Regulatory posture

HIPAA and state law, the EU AI Act for systems operating in Europe, payer and accreditation expectations — translated into decisions your teams can act on rather than a policy nobody reads. See risk & compliance management.

Why this role exists now

Healthcare spent the last few years getting AI in the door. Pilots, ambient documentation, predictive models, triage tools — the technology arrived and, in many organisations, arrived faster than anyone’s ability to govern it. The tools are live. The oversight frequently is not.

That gap is not a technology problem. It is an accountability problem, and it has a specific shape: several tools in production, no single inventory, a committee that meets monthly and cannot say no, and no named person who gets called when something goes wrong. The failure that follows always looks like a model failure in the postmortem and was a leadership vacancy at the time.

When fractional is the right shape: you need the accountability established now, the permanent role is not yet funded or scoped, and the work in the first year is mostly decisions rather than team management. When it isn’t: you already have a functioning governance structure and need execution capacity, or the AI portfolio is large enough to require daily presence and a standing team.

This is the subject Christopher Hutchins wrote Beneath the Signal about, and the through-line of 40 episodes of The Signal Room with 39 named healthcare AI practitioners. The thinking is public before you buy any of it.

Common Questions

What is a fractional Chief AI Officer?

A senior executive who holds accountability for an organization’s AI portfolio part-time under a defined engagement — model inventory, deployment decisions, clinical escalation and regulatory posture — rather than as a permanent hire. In healthcare, the test of the role is whether the person can stop a deployment, not just comment on one.

What does a Chief AI Officer do?

Owns the organization’s AI portfolio end to end: maintaining an inventory of what is actually running, gating which systems deploy, naming who is accountable once they are live, and setting the regulatory posture. In a hospital that also means clinical escalation — who is called when a model is wrong, and whether the clinician who overrides it is supported. The role exists because those decisions otherwise fall between the CMIO, the CISO and the vendor.

What is the difference between a Chief AI Officer and a Chief Data Officer?

A CDAO owns whether the data can be trusted — definitions, governance, reporting integrity. A CAIO owns what is built on top of it: which models deploy, who is accountable once they are live, and how failures escalate. Many health systems need the CDAO work first, because AI governance sitting on an ungoverned data layer governs very little.

Do we need a Chief AI Officer if we already have an AI committee?

Depends whether the committee can say no. A committee with an owner and a real gate is governance. A committee without one is a meeting that produces approvals by exhaustion — and its exceptions are what appear in the postmortem.

How does this work alongside our CMIO and CISO?

It does not replace either. The CMIO owns clinical informatics, the CISO owns security. The CAIO role exists because AI accountability falls between them — a clinically safe model with an unmanaged vendor dependency is nobody’s remit until it is everybody’s problem.

Where does an engagement start?

The inventory, always. You cannot govern a portfolio you cannot enumerate, and the first pass usually finds tools nobody in the room knew were running. That exercise alone often changes what leadership thinks the priority is.

Who owns AI in your organization?

If the answer takes more than one sentence, that's the problem.